EPISODE · Oct 5, 2023 · 46 MIN
Dr Andrée Bates: The World of AI in Healthcare
from Scouting for Growth · host Sabine VdL
On this episode of the Scouting For Growth podcast, Sabine VdL talks to Dr Andrée Bates, neuroscientist and founder of Eularis, an AI-centric company that serves as a catalyst for innovation in healthcare. The pair delves into the pivot points that drive innovation, the ethical implications of widespread AI adoption, and the tangible ways in which artificial intelligence is reshaping healthcare as we know it. KEY TAKEAWAYS Eularis was created to examine mathematics in commercial activities within the pharmaceutical industry. Generative AI takes elements of real data, looks at the database on which it’s been trained, makes new connections, and generates something new. We’re going to have to get to a point where we have some kind of digital certificate in our voice, our video, images, that authenticates whether it’s actually us or not, almost like a digital fingerprint BEST MOMENTS ‘AI is a broad term; there are so many different types of techniques which are classified as artificial intelligence, and under each one, there are different types.’ ‘We can use AI to repurpose existing drugs – and this happened with Covid.’ ‘I’ve recently come across AI that is predicting with very high accuracy whether a drug will be successful or not in the long term. That’s set to revolutionise the industry.’ ABOUT THE GUEST Dr Andrée Bates stands at the intersection of artificial intelligence, healthcare, and entrepreneurship. A seasoned neuroscientist and a disruptive tech innovator, she has trailblazed the healthcare industry since the early '90s. Dr Bates founded Eularis, a vanguard firm leveraging AI to address healthcare's most pressing challenges, back in 2003. Under her leadership, Eularis has catalysed growth for all the top 50 pharmaceutical giants, driving profits and expanding market share through AI-empowered projects in clinical trials, R&D, and medical affairs. After launching her career in academia, Dr. Bates made a seamless transition into the corporate sphere, where she continued her legacy of firsts. She is credited with establishing the world's first digital health company in the 1990s, followed by the pioneering of commercial AI applications in healthcare. This entrepreneurial spirit has positioned her as a go-to advisor for an impressive roster of healthcare CEOs. Her influence extends to both academia and industry circles. Dr. Bates is a sought-after guest lecturer in prestigious MBA programs, including INSEAD Business School and Fordham University, where she instills the next generation with a nuanced understanding of healthcare innovation and AI. A prolific author, her work has appeared in peer-reviewed journals and industry reports. Her international speaking engagements span continents, ranging from Europe and North America to Asia. Never one to limit her impact, Dr Bates actively champions female entrepreneurs worldwide. She serves as a mentor through Thrive Mentoring, contributes to the programming committee of the Healthcare Businesswomen's Association (HBA), and is a founding member of Chief, a network designed for women leaders. ABOUT THE HOST Sabine VanderLinden is a corporate strategist turned entrepreneur and the CEO of Alchemy Crew Ventures. She leads venture-client labs that help Fortune 500 companies adopt and scale cutting-edge technologies from global tech ventures. A builder of accelerators, investor, and co-editor of the bestseller The INSURTECH Book, Sabine is known for asking the uncomfortable questions—about AI governance, risk, and trust. On Scouting for Growth, she decodes how real growth happens—where capital, collaboration, and courage meet. If this episode sparked your thinking, follow Sabine VanderLinden on LinkedIn, Twitter, and Instagram for more insights. And if you’re interested in sponsoring the podcast, reach out to the team at [email protected]
What this episode covers
What if the real breakthrough in healthcare AI isn’t faster algorithms—but trust, ethics, and knowing when not to automate? In this episode of Scouting for Growth, Sabine VdL sits down with Dr Andrée Bates—neuroscientist, entrepreneur, and founder of Eularis—to explore how artificial intelligence is fundamentally reshaping healthcare, pharmaceuticals, and medical decision-making. This is not a speculative discussion about AI’s potential. It’s a grounded, experience-led conversation about what’s already changing—and what must change next if innovation is to be both effective and responsible. Dr Bates has been operating at the intersection of science, technology, and commercial healthcare since the early 1990s. Long before AI became a boardroom buzzword, she was building digital health businesses and applying advanced analytics to real-world medical problems. Eularis itself was born from a precise question: how can mathematics and data be used to improve commercial and clinical outcomes in the pharmaceutical industry? That question has since evolved into AI-driven work spanning R&D, clinical trials, and medical affairs for the world’s top 50 pharma companies. A central theme of the episode is demystification. AI, Dr Bates reminds us, is not a single technology. It’s an umbrella term covering many different techniques—each with different strengths, limitations, and ethical implications. Generative AI, in particular, doesn’t “invent” from nothing. It recombines patterns from the data it has been trained on, creating new outputs based on learned relationships. Understanding that distinction is critical—especially in healthcare, where decisions carry real human consequences. The conversation moves quickly into impact. AI is already transforming drug development timelines, with models capable of predicting—at remarkably high accuracy—whether a drug is likely to succeed long-term. In other cases, AI has enabled the repurposing of existing drugs, dramatically accelerating response times in crises like Covid. These are not marginal gains. They are structural shifts in how healthcare innovation happens. But progress introduces new risks. One of the most striking discussions centres on digital authenticity. As AI-generated voice, video, and imagery become indistinguishable from reality, Dr Bates argues we will need new forms of digital certification—something akin to a biometric fingerprint—to verify what, and who, is real. In healthcare, where trust is foundational, this challenge cannot be ignored. Ethics runs throughout the episode—not as a constraint, but as an enabler of sustainable innovation. AI will only scale in healthcare if patients, clinicians, regulators, and institutions trust how it is used. That requires transparency, governance, and leadership willing to ask difficult questions early. This episode is essential listening for healthcare executives, life sciences leaders, policymakers, and technologists navigating AI adoption under intense regulatory, ethical, and commercial pressure. It’s a reminder that transformation in healthcare isn’t driven by technology alone—it’s driven by judgment. Because in healthcare, the future doesn’t belong to those who move fastest— but to those who move intelligently, ethically, and with humanity at the centre. And that’s exactly what Scouting for Growth is here to uncover.
NOW PLAYING
Dr Andrée Bates: The World of AI in Healthcare
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m